We create and instantiate technologies to enable both large-scale mapping and mechanistic understanding of the epigenome. These fit into the broader toolkit of the Cell Circuits & Epigenomics programs. We have instantiated some of our core technologies for large scale epigenome mapping projects, such as ENCODE4. We also devote significant effort to protocol development in order to work with diverse, complex and rare tissues and cell types.
We currently work with many collaborators to create epigenetic profiles of both healthy and diseased cell populations using the following technologies.
Transcriptomics
RNA-Seq
Single-cell RNA-Seq (including and from the )
Chromatin mapping
ChIP-Seq (transcription factors, chromatin regulators, and histone modifications)
Microfluidic-ChIP
DNA methylation mapping
; including single-cell RRBS)
Whole-genome bisulfite sequencing (WGBS)
Genome topology
Other Assays
Dual (RRBS+RNA)-Seq of low-input samples
Massively parallel reporter assay (MPRA) of enhancer activity
Perturbations
Epigenome engineering
Chromatin regulator CRISPR screens
High throughput small molecule targeting of chromatin factors
How to work with us
The Epigenomics Program operates on a collaborative model. To work with us, please contact Liz Gaskell, Chuck Epstein, or Andi Gnirke with a brief description of your project, your scientific question, funding opportunities, and an idea of scale.
Key papers
Shema E, et al.Science. 2016.
van Galen P, et al. . Mol Cell. 2016.
Rotem A, Ram O, Shoresh N, et al.Nat Biotechnol. 2015.
Mendenhall EM, et al. Nat Biotechnol. 2013.
Ziller MJ, et al.Epigenetics Chromatin. 2016.
Ziller MJ, et al. Nature. 2013.
Brinkman AB, et al. . Genome Res. 2012.
Boyle P, Clement K, Gu H, et al.Genome Biol. 2012.